OVERDUE 510(K) BACKLOG AT FDA DROPS TO 768 IN JULY
This article was originally published in The Gray Sheet
Executive SummaryOVERDUE 510(K) BACKLOG AT FDA DROPS TO 768 IN JULY, down from 836 submissions in June, according to FDAers. The number of 510(k)s under review at FDA's Office of Device Evaluation for more than 90 days continues to drop from the all-time high of 1,978 reached in December 1993 ("The Gray Sheet" March 7, In Brief).
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.